Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pharm ; 341(1-2): 181-8, 2007 Aug 16.
Article in English | MEDLINE | ID: mdl-17553641

ABSTRACT

Although HMG-CoA reductase inhibitors such as statins are the most widely used cholesterol-lowering agents, there is a risk of myopathy or rhabdmyolysis occurring in patients taking these drugs. It has been reported that a number of lipophilic statins cause apoptosis in various cells, but it is still not clear whether intracellular acidification is involved in statin-induced apoptosis. There have been few studies aimed at identifying compounds that suppress statin-induced myotoxicity. In the present study, we examined the relationship between cerivastatin-induced apoptosis and intracellular acidification and the effect of bicarbonate on cerivastatin-induced apoptosis using an RD cell line as a model of in vitro skeletal muscle. Cerivastatin reduced the number of viable cells and caused dramatic morphological changes and DNA fragmentation in a concentration-dependent manner. Moreover, cerivastatin-induced apoptosis was associated with intracellular acidification and caspase-9 and -3/7 activation. On the other hand, bicarbonate suppressed cerivastatin-induced pH alteration, caspase activation, morphological change and reduction of cell viability. Accordingly, bicarbonate suppressed statin-induced apoptosis. The strategy to combine statins with bicarbonate can lead to reduction in the chance of the severe adverse events including myopathy or rhabdmyolysis.


Subject(s)
Apoptosis/drug effects , Fluorobenzenes/toxicity , Hydroxymethylglutaryl-CoA Reductase Inhibitors/toxicity , Muscle, Skeletal/drug effects , Protective Agents/pharmacology , Pyridines/toxicity , Pyrimidines/toxicity , Rhabdomyolysis/prevention & control , Sodium Bicarbonate/pharmacology , Sulfonamides/toxicity , Biological Transport , Caspase 3/metabolism , Caspase 7/metabolism , Caspase 9/metabolism , Cell Line, Tumor , Cell Shape/drug effects , Cell Survival/drug effects , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Enzyme Activation , Fluorobenzenes/metabolism , Humans , Hydrogen-Ion Concentration , Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Protective Agents/therapeutic use , Pyridines/metabolism , Pyrimidines/metabolism , Rhabdomyolysis/chemically induced , Rhabdomyolysis/metabolism , Rhabdomyolysis/pathology , Rhabdomyosarcoma, Embryonal/metabolism , Rhabdomyosarcoma, Embryonal/pathology , Rosuvastatin Calcium , Sodium Bicarbonate/therapeutic use , Sulfonamides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...